CVE:ADK

DIAGNOS - ADK Stock Forecast, Price & News

C$0.40

+0.01 (+2.56%)

(As of 03/24/2023 05:20 PM ET)

Add

Compare

Today's Range: C$0.38
▼
C$0.41
50-Day Range: C$0.32
▼
C$0.43
52-Week Range: C$0.13
▼
C$0.44

Volume: 108,065 shs
Average Volume: 102,600 shs
Market Capitalization: C$27.79 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Stock News Headlines

February 28, 2023 | finance.yahoo.com

DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

December 15, 2022 | finance.yahoo.com

DIAGNOS Provides Additional Information to the Closing of Private Placement

March 26, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.

November 6, 2022 | reuters.com

ADK.V - Diagnos Inc | Stock Price & Latest News | Reuters

October 27, 2022 | finance.yahoo.com

DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology

August 18, 2022 | finance.yahoo.com

DIAGNOS Receives Regulatory Approval from the Costa Rica Health Agency for its Artificial Intelligence Enabled Pathology Detection Systems

July 27, 2022 | finance.yahoo.com

DIAGNOS Continues Expansion in Canada with Kick-off of Services in Endocrinology Clinics with Distribution Partner Labtician Ophthalmics

June 7, 2022 | finance.yahoo.com

DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group

March 26, 2023 | Behind the Markets (Ad)

BREAKING: Tiny biotech successfully treats blindness

February 10, 2022 | finance.yahoo.com

DIAGNOS Successfully Completes ISO / MDSAP Audit

October 28, 2021 | nz.finance.yahoo.com

DIAGNOS Delivers World Class Results in the MICCAI2021 Contest: GAMMA

August 17, 2021 | ca.finance.yahoo.com

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

July 20, 2021 | finance.yahoo.com

DIAGNOS initiates a clinical trial study in the USA for early detection and prevention of Stroke using its new application CARA-STROKE

March 4, 2021 | finance.yahoo.com

DIAGNOS and the third largest optical retailer in Costa Rica Piloting CARA and its Telemedicine technology

March 3, 2021 | finance.yahoo.com

DIAGNOS Announces Stock Options Grants

February 26, 2021 | markets.businessinsider.com

DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update

February 4, 2021 | marketwatch.com

DIAGNOS Announces Further Deployment of its AI based CARA Technology in Saudi Arabia

September 15, 2020 | finance.yahoo.com

DIAGNOS Announces a Multi-Year Contract with Chaparral Medical Group in California

July 20, 2020 | www.bloomberg.com

DIAGNOS Closes Second and Final Tranche of Private Placement

July 14, 2020 | finance.yahoo.com

DIAGNOS Announces Signing of Service Agreement with the Colombian Telemedicine Centre

July 7, 2020 | www.baystreet.ca

Health-Care Stocks on the March

June 12, 2020 | www.barrons.com

Diagnos Inc.

April 27, 2020 | finance.yahoo.com

DIAGNOS Provides Update on its CARA AI Application Participating in US White House Call to Action Data Analysis Program

April 18, 2020 | www.bloomberg.com

DIAGNOS Inc/Canada

March 27, 2020 | www.globenewswire.com

DIAGNOS Announces Stock Options Grant

March 26, 2020 | www.globenewswire.com

DIAGNOS Will Utilize its Artificial Intelligence Medical Platform FLAIRE in Response to the “US White ...

March 9, 2020 | www.globenewswire.com

DIAGNOS Announces Closing of Oversubscribed $2.1 Million Private Placement

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Today: 3/25/2023
Next Earnings (Estimated): 7/12/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Health Information Services
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: CVE:ADK
CUSIP: N/A
CIK: N/A
Web: www.diagnos.ca
Phone: +1-450-6788882
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-2,480,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -121.31%

Debt

Debt-to-Equity Ratio: 245.28
Current Ratio: 1.42
Quick Ratio: 0.68

Sales & Book Value

Annual Sales: C$577,486.00
Price / Sales: 48.12
Cash Flow: C$0.01 per share
Price / Cash Flow: 60.00
Book Value: C($0.02) per share
Price / Book: -20.00

Miscellaneous

Outstanding Shares: 69,470,000
Free Float: N/A
Market Cap: C$27.79 million
Optionable: Not Optionable
Beta: -0.08

Key Executives

Mr. Andre Larente
CEO, Pres & Exec. Director

Mr. Marc-André Massue
VP of Fin., CFO & Sec.

Mr. Guillermo Moreno Robles
VP of Sales

Mr. Martin Beland
Director of Marketing

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?: DIAGNOS's stock was trading at C$0.28 on January 1st, 2023. Since then, ADK stock has increased by 42.9% and is now trading at C$0.40.
View the best growth stocks for 2023 here.
When is DIAGNOS's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023.
View our ADK earnings forecast.
What other stocks do shareholders of DIAGNOS own?: Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).
What is DIAGNOS's stock symbol?: DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?: Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is DIAGNOS's stock price today?: One share of ADK stock can currently be purchased for approximately C$0.40.
How much money does DIAGNOS make?: DIAGNOS (CVE:ADK) has a market capitalization of C$27.79 million and generates C$577,486.00 in revenue each year. The company earns C$-2,480,000.00 in net income (profit) each year or C($0.04) on an earnings per share basis.
How can I contact DIAGNOS?: DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial